Douglas M. Fambrough, III
2018
In 2018, Douglas M. Fambrough, III earned a total compensation of $2.5M as President and Chief Executive Officer at Dicerna Pharmaceuticals, a 102% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $334,719 |
|---|---|
| Option Awards | $1,637,100 |
| Salary | $507,150 |
| Other | $18,592 |
| Total | $2,497,561 |
Fambrough received $1.6M in option awards, accounting for 66% of the total pay in 2018.
Fambrough also received $334.7K in non-equity incentive plan, $507.2K in salary and $18.6K in other compensation.
Rankings
In 2018, Douglas M. Fambrough, III's compensation ranked 4,678th out of 14,244 executives tracked by ExecPay. In other words, Fambrough earned more than 67.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,678 out of 14,244 | 67th |
Division Manufacturing | 1,759 out of 5,762 | 70th |
Major group Chemicals And Allied Products | 636 out of 2,125 | 70th |
Industry group Drugs | 534 out of 1,814 | 71st |
Industry Pharmaceutical Preparations | 413 out of 1,388 | 70th |
Source: SEC filing on April 26, 2019.
Fambrough's colleagues
We found three more compensation records of executives who worked with Douglas M. Fambrough, III at Dicerna Pharmaceuticals in 2018.